Analysed CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) News Sources
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
06-04-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday as Escalation Signals in Iran Conflict Lift Oil Prices
02-04-2026
yahoo.com
Is Celldex’s US$300 Million Follow-On To Fund Barzolvolimab Altering The Investment Case For CLDX?
02-04-2026
yahoo.com
Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026
27-03-2026
yahoo.com
High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding
21-03-2026
fool.com
A Look At Celldex Therapeutics (CLDX) Valuation After Recent Share Price Weakness And Strong 1 Year Return
19-03-2026
yahoo.com
What is the current price of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)?
The current price of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) is $32.24.
CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) since the previous trading day is $-1.38.
CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) since the previous trading day is -4.1047%.
What is the most recent average sentiment score for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)?
The most recent average sentiment score for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)?
The most recent sentiment for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) is .
SEC-8K** Filing Available For CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.